These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 10224507)

  • 1. Development of a simple dry eye model in the albino rabbit and evaluation of some tear substitutes.
    Burgalassi S; Panichi L; Chetoni P; Saettone MF; Boldrini E
    Ophthalmic Res; 1999; 31(3):229-35. PubMed ID: 10224507
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Diquafosol sodium ophthalmic solution for the treatment of dry eye: clinical evaluation and biochemical analysis of tear composition.
    Shigeyasu C; Yamada M; Akune Y; Tsubota K
    Jpn J Ophthalmol; 2015 Nov; 59(6):415-20. PubMed ID: 26310103
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison between two cyclooxygenase inhibitors in an experimental dry eye model in albino rabbits.
    El-Shazly AH; El-Gohary AA; El-Shazly LH; El-Hossary GG
    Acta Pharm; 2008 Jun; 58(2):163-73. PubMed ID: 18515226
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tear osmolarity measurement using the TearLab Osmolarity System in the assessment of dry eye treatment effectiveness.
    Benelli U; Nardi M; Posarelli C; Albert TG
    Cont Lens Anterior Eye; 2010 Apr; 33(2):61-7. PubMed ID: 20153684
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Three percent diquafosol ophthalmic solution as an additional therapy to existing artificial tears with steroids for dry-eye patients with Sjögren's syndrome.
    Yokoi N; Sonomura Y; Kato H; Komuro A; Kinoshita S
    Eye (Lond); 2015 Sep; 29(9):1204-12. PubMed ID: 26160526
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Preservation of tear film integrity and inhibition of corneal injury by dexamethasone in a rabbit model of lacrimal gland inflammation-induced dry eye.
    Nagelhout TJ; Gamache DA; Roberts L; Brady MT; Yanni JM
    J Ocul Pharmacol Ther; 2005 Apr; 21(2):139-48. PubMed ID: 15857280
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Additive Effect of preservative-free sodium hyaluronate 0.1% in treatment of dry eye syndrome with diquafosol 3% eye drops.
    Hwang HS; Sung YM; Lee WS; Kim EC
    Cornea; 2014 Sep; 33(9):935-41. PubMed ID: 25055152
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antioxidant and Osmoprotecting Activity of Taurine in Dry Eye Models.
    Bucolo C; Fidilio A; Platania CBM; Geraci F; Lazzara F; Drago F
    J Ocul Pharmacol Ther; 2018; 34(1-2):188-194. PubMed ID: 28771380
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Topical Porphyrin Antioxidant Protects Against Ocular Surface Pathology in a Novel Rabbit Model for Particulate Matter-Induced Dry Eye Disease.
    Ghosh AK; Bacellar-Galdino M; Iqbal S; Pappenhagen NE; Kaja S
    J Ocul Pharmacol Ther; 2022 May; 38(4):294-304. PubMed ID: 35384749
    [No Abstract]   [Full Text] [Related]  

  • 10. Evaluation of Tear Meniscus Dynamics Using Anterior Segment Swept-Source Optical Coherence Tomography After Topical Solution Instillation for Dry Eye.
    Akiyama-Fukuda R; Usui T; Yoshida T; Yamagami S
    Cornea; 2016 May; 35(5):654-8. PubMed ID: 26989953
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of the clinical course of dry eye syndrome.
    Horwath-Winter J; Berghold A; Schmut O; Floegel I; Solhdju V; Bodner E; Schwantzer G; Haller-Schober EM
    Arch Ophthalmol; 2003 Oct; 121(10):1364-8. PubMed ID: 14557170
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Development of a rabbit model of tear film instability and evaluation of viscosity of artificial tear preparations.
    Nakamura S; Okada S; Umeda Y; Saito F
    Cornea; 2004 May; 23(4):390-7. PubMed ID: 15097136
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of retinoic acid ophthalmic emulsion in dry eye.
    Selek H; Unlü N; Orhan M; Irkeç M
    Eur J Ophthalmol; 2000; 10(2):121-7. PubMed ID: 10887922
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of a new lipid tear substitute in a mouse model of dry eye.
    Scifo C; Barabino S; De Pasquale G; Blanco AR; Mazzone MG; Rolando M
    Cornea; 2010 Jul; 29(7):802-6. PubMed ID: 20489574
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A rabbit dry eye model induced by topical medication of a preservative benzalkonium chloride.
    Xiong C; Chen D; Liu J; Liu B; Li N; Zhou Y; Liang X; Ma P; Ye C; Ge J; Wang Z
    Invest Ophthalmol Vis Sci; 2008 May; 49(5):1850-6. PubMed ID: 18436819
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of chitosan-N-acetylcysteine conjugate in a mouse model of botulinum toxin B-induced dry eye.
    Hongyok T; Chae JJ; Shin YJ; Na D; Li L; Chuck RS
    Arch Ophthalmol; 2009 Apr; 127(4):525-32. PubMed ID: 19365035
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Corneal surface regularity and the effect of artificial tears in aqueous tear deficiency.
    Liu Z; Pflugfelder SC
    Ophthalmology; 1999 May; 106(5):939-43. PubMed ID: 10328393
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Influence of Ophthalmic Solutions on Tear Components.
    Shigeyasu C; Yamada M; Akune Y
    Cornea; 2016 Nov; 35 Suppl 1():S71-S77. PubMed ID: 27661071
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Improvement of corneal barrier function by the P2Y(2) agonist INS365 in a rat dry eye model.
    Fujihara T; Murakami T; Fujita H; Nakamura M; Nakata K
    Invest Ophthalmol Vis Sci; 2001 Jan; 42(1):96-100. PubMed ID: 11133853
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Combining Sodium Hyaluronate and Polyvinylpyrrolidone Therapies for the Rabbit Cornea: A New Approach to Relief of the Human Dry Eye Syndrome.
    Ehrenberg M; Zolotariov E; Loeb E; Poliansky V; Levy A
    Curr Eye Res; 2015 Sep; 40(9):913-22. PubMed ID: 25329624
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.